Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.00082 | 1 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.00072 | 1 |
mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.00054 | 1 |
mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.00054 | 1 |
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.00051 | 1 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.00036 | 1 |
mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.00041 | 1 |